CNS-selective noncompetitive cholinesterase inhibitors derived from the natural piperidine alkaloid (−)-spectaline

作者: Newton G Castro , Rodrigo S Costa , Luisa SB Pimentel , Amanda Danuello , Nelilma C Romeiro

DOI: 10.1016/J.EJPHAR.2007.11.035

关键词:

摘要: Abstract LASSBio-767 [(−)-3- O -acetyl-spectaline] and LASSBio-822 - tert -Boc-spectaline] were recently described as cholinesterase inhibitors derived from the natural piperidine alkaloid (−)-spectaline, obtained flowers of Senna spectabilis (Fabaceae). We investigated their mechanism inhibition acetylcholinesterase efficacy in reversing scopolamine-induced amnesia. Competition assays with substrate acetylthiocholine showed a concentration-dependent reduction rat brain V max without changes apparent K m . The kinetic data for best fit by model simple linear noncompetitive i 6.1 μM 7.5 μM, respectively. A dilution assay fast complete reversal inhibition, independent incubation time. Simulated docking compounds into catalytic gorge Torpedo interactions peripheral anionic site, but not triad. Anti-amnestic effects mice assessed step-down passive avoidance test Morris water maze 30 min after injection scopolamine (1 mg/kg i.p.). Saline, LASSBio-767, or was administered 15 min before scopolamine. Both reversed latency at 0.1 mg/kg i.p. escape 1 mg/kg p.o., while its cholinergic side absent mild up to 30 mg/kg (LD 50 above 100 mg/kg Thus, (−)-spectaline derivatives are potent agents vivo, unique profile combining CNS selectivity, few effects.

参考文章(58)
Albert Enz, Rene Amstutz, H. Boddeke, G. Gmelin, J. Malanowski, BRAIN SELECTIVE-INHIBITION OF ACETYLCHOLINESTERASE - A NOVEL-APPROACH TO THERAPY FOR ALZHEIMERS-DISEASE Progress in Brain Research. ,vol. 98, pp. 431- 438 ,(1993) , 10.1016/S0079-6123(08)62429-2
P F Glidden, F J Ehlert, M T Griffin, The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor. Journal of Pharmacology and Experimental Therapeutics. ,vol. 279, pp. 1335- 1344 ,(1996)
Jacqueline S Birks, Cholinesterase inhibitors for Alzheimer's disease Cochrane Database of Systematic Reviews. ,(2006) , 10.1002/14651858.CD005593
D E Selk, W Petko, H M Vargas, G M Bores, V Wolf, L Davis, D K Rush, A E Mutlib, F Camacho, R W Kosley, F P Huger, Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. Journal of Pharmacology and Experimental Therapeutics. ,vol. 277, pp. 728- 738 ,(1996)
Z Radić, E Reiner, P Taylor, Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. Molecular Pharmacology. ,vol. 39, pp. 98- 104 ,(1991)
S. E. Black, R. Doody, H. Li, T. McRae, K. M. Jambor, Y. Xu, Y. Sun, C. A. Perdomo, S. Richardson, Donepezil preserves cognition and global function in patients with severe Alzheimer disease Neurology. ,vol. 69, pp. 459- 469 ,(2007) , 10.1212/01.WNL.0000266627.96040.5A
George L. Ellman, K.Diane Courtney, Valentino Andres, Robert M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity Biochemical Pharmacology. ,vol. 7, pp. 88- 95 ,(1961) , 10.1016/0006-2952(61)90145-9
Holger Claußen, Christian Buning, Matthias Rarey, Thomas Lengauer, FlexE: efficient molecular docking considering protein structure variations. Journal of Molecular Biology. ,vol. 308, pp. 377- 395 ,(2001) , 10.1006/JMBI.2001.4551
Scott J. Weiner, Peter A. Kollman, David A. Case, U. Chandra Singh, Caterina Ghio, Guliano Alagona, Salvatore Profeta, Paul Weiner, A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS Journal of the American Chemical Society. ,vol. 106, pp. 765- 784 ,(1984) , 10.1021/JA00315A051